|
[Related PubMed/MEDLINE] Total Number of Papers: 36
|
|
|
[Display Entries]
|
|
[Entries Per Page]
|
per page
|
|
Page Control
|
|
Page: of
|
|
|
|
Abbreviation |
: GePaRD |
Long Form |
: German Pharmacoepidemiological Research Database |
|
No. |
Year |
Title |
Co-occurring Abbreviation |
1 |
2022 |
Characteristics of New Users of Aclidinium Bromide, Aclidinium/Formoterol, and Other COPD Medications in the United Kingdom, Denmark, and Germany. |
COPD, LABA |
2 |
2022 |
Estimating Incidence and Case Fatality of Thyroid Storm in Germany Between 2007 and 2017: A Claims Data Analysis. |
CI 0.2-4.0, CIs |
3 |
2022 |
Investigating drug safety in pregnancy based on the German Pharmacoepidemiological Research Database (GePaRD): A proof-of-concept analysis on the association between valproate and spina bifida. |
CI, VPA |
4 |
2022 |
Polyp detection rate and cumulative incidence of post-colonoscopy colorectal cancer in Germany. |
PCCRC, PDR |
5 |
2022 |
Record linkage of claims and cancer registries data-Evaluation of a deterministic linkage approach based on indirect personal identifiers. |
--- |
6 |
2022 |
Regional Variations in Outpatient Antibiotic Prescribing in Germany: A Small Area Analysis Based on Claims Data. |
--- |
7 |
2022 |
Second dose of measles-mumps-rubella-varicella vaccine (MMRV) and the risk of febrile convulsions. |
CIs, FC, MMR, MMRV, OR |
8 |
2022 |
Validation of Algorithms to Identify Acute Myocardial Infarction, Stroke, and Cardiovascular Death in German Health Insurance Data. |
AMI, CV, PPVs |
9 |
2021 |
Anticholinergic burden: First comprehensive analysis using claims data shows large variation by age and sex. |
AB, ACB |
10 |
2021 |
Avoiding Time-Related Biases: A Feasibility Study on Antidiabetic Drugs and Pancreatic Cancer Applying the Parametric g-Formula to a Large German Healthcare Database. |
T2DM |
11 |
2021 |
Characterization of pregnancies exposed to St. John's wort and their outcomes: A claims data analysis. |
--- |
12 |
2021 |
Repeated Use of Prescription Drugs in Pediatrics: Comprehensive Overview Based on German Claims Data. |
--- |
13 |
2020 |
Estimating the Beginning of Pregnancy in German Claims Data: Development of an Algorithm With a Focus on the Expected Delivery Date. |
EDD, LMP |
14 |
2020 |
How often are antidepressants prescribed off-label among older adults in Germany? A claims data analysis. |
--- |
15 |
2020 |
Individual Antidepressants and the Risk of Fractures in Older Adults: A New User Active Comparator Study. |
ADs, aORs, CIs, ID |
16 |
2020 |
Prescribing of menopausal hormone therapy in Germany: Current status and changes between 2004 and 2016. |
MHT, WHI |
17 |
2019 |
Antidepressants and the Risk of Hemorrhagic Stroke in the Elderly: a Nested Case-Control Study. |
ADs, CIs, HS, ORs, SSRIs |
18 |
2019 |
Individual mortality information in the German Pharmacoepidemiological Research Database (GePaRD): a validation study using a record linkage with a large cancer registry. |
SHIs |
19 |
2018 |
Optimizing an algorithm for the identification and classification of pregnancy outcomes in German claims data. |
--- |
20 |
2018 |
[Enrichment of Claims Data with Official Causes of Death Using a Record Linkage with the Epidemiological Cancer Registry of North Rhine-Westphalia: Feasibility Study and Comparison of Procedures]. |
NRW, SHI |
21 |
2017 |
Characterization of new users of cilostazol in the UK, Spain, Sweden, and Germany. |
--- |
22 |
2017 |
Non-Steroidal Anti-Inflammatory Drug Use and the Risk of Acute Myocardial Infarction in the General German Population: A Nested Case-Control Study. |
AMI, CIs, DDDs, NSAIDs, ORs |
23 |
2017 |
The Risk of Ischemic Cardio- and Cerebrovascular Events Associated with Oxycodone-Naloxone and Other Extended-Release High-Potency Opioids: A Nested Case-Control Study. |
aORs, CIs, ER, HPO, IS, MI |
24 |
2016 |
Frequency and trends of disease-modifying antirheumatic drug (DMARD) use in Germany. |
DMARD |
25 |
2016 |
Prescribing pattern of antipsychotic drugs during the years 1996-2010: a population-based database study in Europe with a focus on torsadogenic drugs. |
APDs, ERD, HSD, IPCI, PYs, SCD, TdP |
26 |
2016 |
Risk of Stroke after Herpes Zoster - Evidence from a German Self-Controlled Case-Series Study. |
HZ, HZO, IRR, VZV |
27 |
2016 |
Validating mortality in the German Pharmacoepidemiological Research Database (GePaRD) against a mortality registry. |
BreMI |
28 |
2015 |
Mortality in the German Pharmacoepidemiological Research Database (GePaRD) compared to national data in Germany: results from a validation study. |
FSOG |
29 |
2015 |
The proportion of all previous patients was a potential instrument for patients' actual prescriptions of nonsteroidal anti-inflammatory drugs. |
COX-2, tNSAIDs |
30 |
2015 |
The Risk of Opioid Intoxications or Related Events and the Effect of Alcohol-Related Disorders: A Retrospective Cohort Study in German Patients Treated with High-Potency Opioid Analgesics. |
aIRR, ARDs, CI, HPO, IRs |
31 |
2014 |
Estimation of background incidence rates of Guillain-Barre syndrome in Germany - a retrospective cohort study with electronic healthcare data. |
GBS, IRRs, IRs, SIRs |
32 |
2013 |
Comorbidities in ADHD children treated with methylphenidate: a database study. |
ADHD, MPH |
33 |
2013 |
Evaluation of pregnancy outcome records in the German Pharmacoepidemiological Research Database (GePaRD). |
--- |
34 |
2013 |
Twin and sibling studies using health insurance data: the example of attention deficit/hyperactivity disorder (ADHD). |
ADHD |
35 |
2012 |
Age-specific prevalence, incidence of new diagnoses, and drug treatment of attention-deficit/hyperactivity disorder in Germany. |
ADHD, CI, ICD-10 |
36 |
2011 |
Linkage of mother-baby pairs in the German Pharmacoepidemiological Research Database. |
MBPs, SHIs |
|